We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Mecasermin, also known as recombinant human insulin-like growth factor-1 (rhIGF-1), is a recombinant form of human insulin-like growth factor 1 (IGF-I) which is used in the long-term treatment of growth failure and short stature in children with severe primary IGF-I deficiency, for instance due to growth hormone deficiency or Laron syndrome (growth hormone insensitivity).
CAT No: 10-101-335
CAS No: 68562-41-4
Synonyms/Alias: FK-780; Recombinant human insulin-like growth factor-1; rhIGF-1; Somatomedin-1
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C331H512N94O101S7 |
M.W/Mr. | 7648.71 |
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.